-+ 0.00%
-+ 0.00%
-+ 0.00%

Shengnuo Pharmaceutical-B (02257) establishes an external scientific advisory committee

Zhitongcaijing·07/21/2026 09:09:04
Listen to the news

Zhitong Finance App News, Shengnuo Pharmaceutical-B (02257) issued an announcement. On July 21, 2026, the company established an external scientific advisory committee (scientific advisory committee) to provide independent and authoritative scientific guidance for the Group's treatment pipeline research and development projects. The Scientific Advisory Board consists of five internationally renowned interdisciplinary experts with deep expertise in RNA delivery technology, RNAi drug discovery, oncology research and development (R&D), clinical translational medicine, chemistry, manufacturing and control (CMC) activities, and global drug regulatory compliance.